Trial intelligence / Profile preview

Compared Effects of Three Beta Blockers on Exercise Capacity and Pulmonary Function in Chronic Heart Failure

2007-003781-17Phase 2Completed

Sponsor
Centro Cardiologico Monzino
Start
Aug 2007
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of carvedilol, bisoprolol and nebivolol in chronic heart failure (CHF) (3 arms), sponsored by Centro Cardiologico Monzino. Primary endpoints: Change in diffusing capacity of the lung for carbon monoxide (DLco), Change in central ventilatory response to hypercapnia and 1 more. Started Aug 2007; status: completed.

02

Drugs

carvedilolbisoprololnebivolol
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on 2007-003781-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003781-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call